메뉴 건너뛰기




Volumn 18, Issue 16, 2010, Pages 5775-5794

Process R&D under the magnifying glass: Organization, business model, challenges, and scientific context

Author keywords

Organic synthesis; Pharmaceuticals; Process design; Process R D; Scale up

Indexed keywords

AR A2; CHROMAN DERIVATIVE; EBALZOTAN; ESOMEPRAZOLE; FLUOXETINE; MONOCLONAL ANTIBODY; OMEPRAZOLE; POTASSIUM CARBONATE; ROBALZOTAN; ROPIVACAINE; SEROTONIN 1B ANTAGONIST; UNCLASSIFIED DRUG; ZIMELDINE;

EID: 77955471836     PISSN: 09680896     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmc.2010.06.029     Document Type: Review
Times cited : (26)

References (55)
  • 38
    • 77955466194 scopus 로고    scopus 로고
    • Patent Appl. WO 99/59988
    • Eriksson, M. Patent Appl. WO 99/59988, 1999.
    • (1999)
    • Eriksson, M.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.